(Q39451596)

12 September 2017

title

S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma (English)

1 reference

12 September 2017

1 reference

K Lee

1

1 reference

12 September 2017

S-T Yun

2

1 reference

12 September 2017

C-O Yun

3

1 reference

12 September 2017

B-Y Ahn

4

1 reference

12 September 2017

E-C Jo

5

1 reference

12 September 2017

publication date

27 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

967-977

1 reference

Development of transcriptionally regulated oncolytic adenoviruses

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Recent progress in the battle between oncolytic viruses and tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Oncolytic (replication-competent) adenoviruses as anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

S100A2 induces metastasis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

EGF stimulates transcription of CaN19 (S100A2) in HaCaT keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Biochemical characterization of S100A2 in human keratinocytes: subcellular localization, dimerization, and oxidative cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Down-regulation of S100A2 in lymph node metastases of head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Positive selection of candidate tumor-suppressor genes by subtractive hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

A quantitative promoter methylation profile of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

DNA methylation and viral gene expression in adenovirus-transformed and-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Spatial control of EGF receptor activation by reversible dimerization on living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Is there a role for cetuximab in non small cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Mechanisms of resistance to HER family targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

Expression profiling of primary non-small cell lung cancer for target identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

S100A2 in cancerogenesis: a friend or a foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

7 January 2021

Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

7 January 2021

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

7 January 2021

The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.168

7 January 2021

Identifiers

DOI

10.1038/GT.2011.168

1 reference

Dimensions Publication ID

12 September 2017

1039440683

0 references

1 reference